bicalutamide
Showing 1 - 25 of 108
Metastatic Breast Cancer (MBC) Trial in United States (Palbociclib, Bicalutamide)
Active, not recruiting
- Metastatic Breast Cancer (MBC)
- Palbociclib
- Bicalutamide
-
Basking Ridge, New Jersey
- +4 more
Oct 31, 2022
Non-Muscle Invasive Bladder Cancer Trial in Québec (Bicalutamide, Control Arm)
Recruiting
- Non-Muscle Invasive Bladder Cancer
- Bicalutamide
- Control Arm
-
Québec, CanadaCHU de Québec-Université Laval
Jul 13, 2022
Triple Negative Breast Cancer Trial in United States (ribociclib, Bicalutamide)
Recruiting
- Triple Negative Breast Cancer
- ribociclib
- Bicalutamide
-
Chicago, Illinois
- +5 more
Oct 31, 2022
Breast Cancer Trial in United States (bicalutamide, diagnostic laboratory biomarker analysis, immunohistochemistry staining
Completed
- Breast Cancer
- bicalutamide
- +2 more
-
San Francisco, California
- +7 more
Jul 8, 2022
Prostate Adenocarcinoma Trial run by the (bicalutamide, Stereotactic body radiation therapy)
Recruiting
- Prostate Adenocarcinoma
- bicalutamide
- Stereotactic body radiation therapy
-
Bethesda, MarylandNational Cancer Institute
Oct 1, 2021
Breast Cancer, Metastasis Trial in New York (Abemaciclib, Bicalutamide)
Recruiting
- Breast Cancer
- Metastasis
- Abemaciclib
- Bicalutamide
-
New York, New York
- +2 more
Oct 14, 2021
Prostate Cancer Trial in Madison (Docetaxel, Degarelix, Bicalutamide)
Completed
- Prostate Cancer
- Docetaxel
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Sep 12, 2022
Prostate Cancer Trial in Washington, Baltimore (drug, procedure, radiation)
Completed
- Prostate Cancer
- Leuprolide Acetate
- +4 more
-
Washington, District of Columbia
- +2 more
Jul 11, 2022
Prostate Cancer Trial in Washington, Baltimore (Leuprolide Acetate, Docetaxel, Bicalutamide)
Active, not recruiting
- Prostate Cancer
- Leuprolide Acetate
- +4 more
-
Washington, District of Columbia
- +1 more
Mar 29, 2022
Prostate Cancer Trial in United States (Bicalutamide, GnRH Agonist, Radiation Therapy)
Recruiting
- Prostate Cancer
- Bicalutamide
- +3 more
-
Stamford, Connecticut
- +4 more
May 12, 2022
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Birmingham, Detroit, Columbus
Active, not recruiting
- Adenocarcinoma of the Prostate
- +2 more
- enzalutamide
- +5 more
-
Birmingham, Alabama
- +3 more
Mar 2, 2021
Salivary Gland Tumors Trial in Shanghai (Pyrotinib, Bicalutamide, Leuprorelin)
Recruiting
- Salivary Gland Neoplasms
- Pyrotinib
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Ton
Oct 8, 2021
Prostate Cancer Trial in Chicago (Bicalutamide, Dutasteride, Finasteride)
Active, not recruiting
- Prostate Cancer
- Bicalutamide
- +3 more
-
Chicago, IllinoisUniversity of Chicago
Sep 30, 2021
PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Duarte, South Pasadena (drug, radiation, other)
Active, not recruiting
- PSA Level Greater Than Two
- Stage IV Prostate Adenocarcinoma AJCC v7
- Bicalutamide
- +4 more
-
Duarte, California
- +1 more
Apr 4, 2022
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Stanford (radiation, drug, other)
Active, not recruiting
- Prostate Adenocarcinoma
- +4 more
- Internal Radiation Therapy
- +7 more
-
Stanford, CaliforniaStanford University, School of Medicine
Feb 1, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)
Active, not recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Abiraterone Acetate
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Prostate Cancer Trial in France (drug, procedure, radiation)
Completed
- Prostate Cancer
- bicalutamide
- +6 more
-
Angers, France
- +37 more
Jan 17, 2023
Prostate Cancer, Bone Metastases, Prostate Tumors Trial in United States (LHRH agonist/antagonist, Bicalutamide, Radium-223
Terminated
- Prostate Cancer
- +2 more
- LHRH agonist/antagonist
- +2 more
-
Phoenix, Arizona
- +11 more
Jul 7, 2022
High-risk Prostate Cancer, Prostate Cancer Trial in Houston (drug, radiation, procedure)
Recruiting
- High-risk Prostate Cancer
- Prostate Cancer
- HSV-Tk
- +5 more
-
Houston, TexasHouston Methodist Hospital
Apr 5, 2021
Prostate Cancer Trial in Toronto (drug, procedure, radiation)
Completed
- Prostate Cancer
- bicalutamide
- +4 more
-
Toronto, Ontario, CanadaToronto Sunnybrook Regional Cancer Centre
Oct 21, 2020
Breast Cancer Trial in Groningen (Bicalutamide, FDHT PET)
Completed
- Breast Cancer
- Bicalutamide
- FDHT PET
-
Groningen, NetherlandsUniversity Medical Center Groningen
Nov 26, 2019
Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )
Completed
- Prostate Cancer
- bicalutamide
- +2 more
-
Birmingham, Alabama
- +239 more
May 23, 2022